• Medicine
  • Published in
    Clinical infectious diseases…
    2001
  • DOI:10.1086/317548

Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.

@article{Roemer2001ToxoplasmosisAS,
  title={Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.},
  author={Ernst Roemer and I W Blau and Nadezda Basara and M. Kiehl and M J Bischoff and S. Guenzelmann and Detlef Kirsten and H. S{\'a}nchez and E L Wocker and Axel A. Fauser},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2001},
  volume={32 1},
  pages={
          E1-8
        }
}
Toxoplasmosis is a rare but often fatal complication that occurs after patients undergo allogeneic hematopoietic stem cell transplant. At our institution, toxoplasmosis was diagnosed in 8 of 301 patients who received stem cell transplants. Disseminated toxoplasmosis with a rapid fatal course was observed in 2 patients. Six patients had cerebral toxoplasmosis diagnosed on the basis of neurological signs and observation of the patients' mental confusion, seizures, and typical lesions (which were… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 32 CITATIONS

Analytic Review: Neurological Complications of Transplantation

VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Re-infection of Toxoplasma gondii after HSCT presenting lymphadenopathy resembling recurrence of lymphoma.

VIEW 1 EXCERPT

Disseminated toxoplasmosis after hematopoietic stem cell transplantation showing unusual magnetic resonance images.

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 50 REFERENCES

Incidence and risk

  • F Belanger, F Derouin, L Grangeot-Keros
  • Clin Infect Dis
  • 1999
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Late toxoplasmosis evidenced by PCR in a marrow transplant recipient.

VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.

VIEW 2 EXCERPTS

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk.

Opportunistic CNS infection after bone marrow transplantation

VIEW 1 EXCERPT